We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go: Expired investment: £1,146,318
No Agent helps landlords to manage and market their properties. No agent have created a much simpler way for landlords to manage the entire rental process which includes marketing, administration, management and 24/7 support for one fixed monthly fee.
days to go: Expired investment: £584,162
A premium bicycle manufacturer that has created a fold-able and chinless e-bike for those that want to cycle more regularly. JIVR's e-bikes carry a 250W electric motor with a range of 50km on a single charge and can be folded in seconds whilst weighing 18kg. The company's executive team consists of individuals from Tesla, BMW, Jaguar and Pepsi and has received media coverage from high-profile outlets including the BBC, Forbes, Netflix, Amazon and many others. JIVR has multiple sales channels including B2C, B2B2C and B2B and is achieving a gross profit margin of 47.5% for every bike sold. This crowdfunding round will enable JIVR to further establish their e-commerce sales channels, create 4 new products targeted at different levels of the market and enhance the technological aspect of their e-bikes to develop new features and functionalities to ensure an improved safety and rider experience.
days to go: Expired investment: €954,520
Rightangled are a CQC registered healthcare provider specialising in genetic testing and is backed by the NHS England. They have designed and filed a patent for their Cardiac genetic test and are now seeking to expand their testing and telemedicine service into new markets and new tests.
days to go: Expired investment: £433,290
Qure’s aim is to provide individual healthcare that is both affordable and highly convenient, becoming the platform of choice for both patients and practitioners. Qure offer 24/7 private healthcare, without the huge price tag that is usually associated with these kinds of services. 
days to go: Expired investment: £1,162,206
Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
days to go: Expired investment: £465,150
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £211,595
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go: Expired investment: £76,030
Propetly is an online platform that acts as a connecting hub between investment providers and global investors in the field of real estate. It enables potential property investors to find, evaluate and calculate their investment project within minutes. With the help of AI-enabled architecture, Propetly can verify transactions on its portal, suggest finance options and ensure complete diligence of the transaction as per industry benchmarks. Given the relative lack of professional and up-to-date property investors in the UK, Propetly aims to become the one-stop-shop for all real estate deals. Its offering has led to Propetly being counted amongst leading PropTech brands in the UK. With the funds received, Propetly will invest in paid advertising and PR, upgrade its AI systems to enable more options are available to customers across wide demographics and human resources.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £235,079
Borrow A Boat (BaB) is a boat charter company that allows customers to book boats of all types online for charter - whether a short-notice request for day hire, a long weekend on board, or a 7-14 day boating trip for an upcoming summer holiday. The company asserts that it is the UK's leading boat charter marketplace with access to over 35,000 boats listed in 65+ countries. BaB was the headline sponsor of the UK's biggest boat show in 2019 - the Southampton International Boat Show. It claims that the global yacht charter market is projected to reach $25 billion by 2027. BaB aims to make boating easier than ever for people and become the segment leader. The company intends to launch into eight new countries in 2021. It will use 60% of the investment for paying its in-house tech team who are developing the user experience and automation of the BAB portal and app, 35% for digital marketing including content, and 5% towards covering company overheads such as accounting and legal.
days to go: Expired investment: £501,710
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph